Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Nemaura Medical Inc | NMRD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.1053 | 0.1053 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.0988 - 1.25 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.1053 | USD |
Nemaura Medical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.44M | 28.90M | - | 77k | -14.14M | -0.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nemaura Medical News
Date | Time | Source | News Article |
---|---|---|---|
4/19/2024 | 15:05 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements |
4/10/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
2/26/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
1/22/2024 | 15:15 | GlobeNewswire Inc. | Maxim Group LLC to Host the 2024 Healthcare IT Virtual.. |
1/17/2024 | 16:17 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
1/17/2024 | 16:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
1/09/2024 | 16:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
1/09/2024 | 16:29 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
1/03/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
1/03/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
1/03/2024 | 06:00 | GlobeNewswire Inc. | Important Update on Listing Status and Strategic Direction |
12/13/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NMRD Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.26 | 0.2801 | 0.0988 | 0.1843828 | 198,099 | -0.1547 | -59.50% |
1 Year | 0.71 | 1.25 | 0.0988 | 0.4222182 | 158,446 | -0.6047 | -85.17% |
3 Years | 4.84 | 17.40 | 0.0988 | 7.93 | 243,396 | -4.73 | -97.82% |
5 Years | 0.98 | 17.40 | 0.0988 | 7.51 | 171,235 | -0.8747 | -89.26% |
Nemaura Medical Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter with an app displaying glucose readings at five minute intervals for periods up to 24 hours. |